Rethink your diabetes management. Redefine your life.

Sleeping in late, dancing 'til dawn, taking the scenic route, without the restrictions of injecting insulin and eating at a certain time.

Live More, Worry Less

In its own class.

The MiniMed® Paradigm® Veo™ Insulin Pump and Continuous Glucose Monitoring (CGM) System3 is the cornerstone of your new diabetes management system.

With the MiniMed® Paradigm® Veo™ you can benefit from:

Reduced Risk of Severe Hypoglycemia4

With its exclusive Low Glucose Suspend (LGS) feature, the Veo™ makes it possible for you and your loved ones to sleep a little easier at night by reducing the risk of severe hypoglycemic events.4

Early Detection of Highs and Lows

Get advanced warning of approaching high and low excursions with the latest Continuous Glucose Monitoring (CGM) features, such as Predictive Alerts and Rate of Change Alerts.

Better Glucose Control

A large scale clinical trial showed that an insulin pump with CGM can help you achieve better glucose control without an increase in hypoglycemia and reduce the risks of long term complications.

Freedom and Flexibility

Eat, sleep, and exercise whenever you want with advanced insulin delivery features that can accommodate just about any lifestyle. Now you can take more control over your diabetes!

The MiniMed® Paradigm® Veo™ represents a major breakthrough in the history of diabetes management and our commitment to developing a fully automated device. Click here to get started on your own journey towards closing the loop!

Continue

  1. The Diabetes Control and Complications Trial (DCCT) Research Group. The eff ect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM. 1993;329(14):977-986.
  2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. NEJM. 2005;353(25):2643-2653.
  3. The Continuous Glucose Monitoring system requires the use of the MiniLink™ transmitted and glucose sensors (sold separately).
  4. Keenan, B., Cartaya, R., Mastrototaro, J. Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm. J Diabetes Sci Technol. 2010;4(1):111-118.

Request Information

If you would like more information as it becomes available, please complete the form linked below.

Sign Up Now!